NORTHERN TRUST CORP - SEELOS THERAPEUTICS INC ownership

SEELOS THERAPEUTICS INC's ticker is SEEL and the CUSIP is 81577F109. A total of 82 filers reported holding SEELOS THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.65 and the average weighting 0.0%.

Quarter-by-quarter ownership
NORTHERN TRUST CORP ownership history of SEELOS THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$37,876
-84.6%
205,847
-0.2%
0.00%
Q2 2023$246,374
+81.7%
206,171
+5.1%
0.00%
Q1 2023$135,601
+8.6%
196,182
+6.6%
0.00%
Q4 2022$124,919
-33.9%
183,9750.0%0.00%
Q3 2022$189,000
+56.2%
183,975
+3.0%
0.00%
Q2 2022$121,000
-83.4%
178,622
-79.4%
0.00%
Q1 2022$728,000
-50.7%
868,793
-4.0%
0.00%
Q4 2021$1,476,000
-32.9%
905,277
-0.8%
0.00%
Q3 2021$2,200,000
+9.6%
912,864
+20.1%
0.00%
Q2 2021$2,007,000
+228.5%
760,056
+520.8%
0.00%
Q1 2021$611,000
+330.3%
122,430
+35.8%
0.00%
Q4 2020$142,000
+89.3%
90,142
+13.2%
0.00%
Q3 2020$75,000
-24.2%
79,625
-18.5%
0.00%
Q2 2020$99,000
+607.1%
97,699
+237.4%
0.00%
Q1 2020$14,000
-46.2%
28,956
+50.4%
0.00%
Q4 2019$26,000
+4.0%
19,258
-28.9%
0.00%
Q3 2019$25,0000.0%27,078
+136.4%
0.00%
Q2 2019$25,00011,4520.00%
Other shareholders
SEELOS THERAPEUTICS INC shareholders Q4 2022
NameSharesValueWeighting ↓
SABBY MANAGEMENT, LLC 508,000$249,0000.10%
1492 Capital Management LLC 150,000$74,0000.09%
Uniplan Investment Counsel, Inc. 2,069,121$1,014,0000.08%
ARDSLEY ADVISORY PARTNERS LP 70,000$34,0000.01%
Spark Investment Management LLC 35,210$17,0000.01%
TOCQUEVILLE ASSET MANAGEMENT L.P. 191,000$94,0000.00%
WealthPLAN Partners, LLC 20,000$15,0000.00%
Procyon Advisors, LLC 2,500$1,0000.00%
Renaissance Technologies 1,078,379$529,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of SEELOS THERAPEUTICS INC shareholders